Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sandra M. Gurrola currently holds 110 shares of Eterna Therapeutics Inc. (ERNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sandra M. Gurrola has been a net neutral trader of ERNA stock. They have purchased $0 and sold $0 worth of shares.
Sandra M. Gurrola's most recent insider trade was on Jun 21, 2025, when they sold 30 shares at $0.00 per share.
Sandra M. Gurrola serves as Executive at Eterna Therapeutics Inc. (ERNA). They have executed 43 insider transactions totaling $0 over their tenure at the company.
Sandra M. Gurrola holds the position of Executive at Eterna Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Sandra M. Gurrola has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Sandra M. Gurrola was on Mar 24, 2021, when they sold $16.3K worth of BTX shares. This transaction involved 6,094 shares at $2.67 per share.
Sandra M. Gurrola currently owns 110 shares of Eterna Therapeutics Inc. (ERNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sandra M. Gurrola's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sandra M. Gurrola has 43 Form 4 filings on record as an insider at Eterna Therapeutics Inc..
Set alerts for Sandra M. Gurrola and 40,000+ other insiders.